Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation

W. D. Haire, R. P. Lieberman, J. Edney, W. P. Vaughan, A. Kessinger, James Olen Armitage, J. C. Goldsmith

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

One hundred sixty‐eight bone marrow transplant recipients and 49 patients who received high‐dose chemotherapy were evaluated for symptomatic thrombosis after Hickman catheter placement. The timing of thrombotic complications was different between these two groups, with the transplant group having a significantly lower thrombus‐free survival by 28 days after catheter placement. By 100 days after placement the thrombus‐free survival rates of the two groups were similar. The platelet count at time of catheter placement was significantly lower in the nontransplant group, and the thrombus‐free survival was longer in patients whose catheter was placed when their platelet count was less than 150,000, suggesting that thrombocytopenia delays thrombotic complications. Placement of two Hickman catheters resulted in a 12.9% thrombosis rate (21 of 162 patients) and was significantly more likely to be associated with thrombosis than placement of one catheter. Long‐term follow‐up evaluation of patients treated without successful fibrinolytic therapy showed no residual symptoms of venous obstruction. In those patients presenting with concomitant catheter obstruction resulting from thrombosis, low‐dose fibrinolytic therapy was successful in restoring catheter function 70% of the time. Placement of two Hickman catheters is associated with an inordinate incidence of thrombosis. Thrombocytopenia at the time of catheter placement may delay this complication. Thrombotic catheter obstruction can be treated successfully with low‐dose fibrinolytic therapy. Even without fibrinolytic therapy, catheter‐induced subclavian vein thrombosis rarely causes long‐term disability.

Original languageEnglish (US)
Pages (from-to)900-908
Number of pages9
JournalCancer
Volume66
Issue number5
DOIs
StatePublished - Sep 1 1990

Fingerprint

Veins
Thrombosis
Thorax
Catheters
Transplantation
Bone Marrow
Drug Therapy
Thrombolytic Therapy
Catheter Obstruction
Platelet Count
Thrombocytopenia
Subclavian Vein
Survival
Survival Rate
Transplants
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation. / Haire, W. D.; Lieberman, R. P.; Edney, J.; Vaughan, W. P.; Kessinger, A.; Armitage, James Olen; Goldsmith, J. C.

In: Cancer, Vol. 66, No. 5, 01.09.1990, p. 900-908.

Research output: Contribution to journalArticle

Haire, W. D. ; Lieberman, R. P. ; Edney, J. ; Vaughan, W. P. ; Kessinger, A. ; Armitage, James Olen ; Goldsmith, J. C. / Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation. In: Cancer. 1990 ; Vol. 66, No. 5. pp. 900-908.
@article{d488d0c7ec8d47be9946a0bdcedaf28c,
title = "Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation",
abstract = "One hundred sixty‐eight bone marrow transplant recipients and 49 patients who received high‐dose chemotherapy were evaluated for symptomatic thrombosis after Hickman catheter placement. The timing of thrombotic complications was different between these two groups, with the transplant group having a significantly lower thrombus‐free survival by 28 days after catheter placement. By 100 days after placement the thrombus‐free survival rates of the two groups were similar. The platelet count at time of catheter placement was significantly lower in the nontransplant group, and the thrombus‐free survival was longer in patients whose catheter was placed when their platelet count was less than 150,000, suggesting that thrombocytopenia delays thrombotic complications. Placement of two Hickman catheters resulted in a 12.9{\%} thrombosis rate (21 of 162 patients) and was significantly more likely to be associated with thrombosis than placement of one catheter. Long‐term follow‐up evaluation of patients treated without successful fibrinolytic therapy showed no residual symptoms of venous obstruction. In those patients presenting with concomitant catheter obstruction resulting from thrombosis, low‐dose fibrinolytic therapy was successful in restoring catheter function 70{\%} of the time. Placement of two Hickman catheters is associated with an inordinate incidence of thrombosis. Thrombocytopenia at the time of catheter placement may delay this complication. Thrombotic catheter obstruction can be treated successfully with low‐dose fibrinolytic therapy. Even without fibrinolytic therapy, catheter‐induced subclavian vein thrombosis rarely causes long‐term disability.",
author = "Haire, {W. D.} and Lieberman, {R. P.} and J. Edney and Vaughan, {W. P.} and A. Kessinger and Armitage, {James Olen} and Goldsmith, {J. C.}",
year = "1990",
month = "9",
day = "1",
doi = "10.1002/1097-0142(19900901)66:5<900::AID-CNCR2820660515>3.0.CO;2-A",
language = "English (US)",
volume = "66",
pages = "900--908",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation

AU - Haire, W. D.

AU - Lieberman, R. P.

AU - Edney, J.

AU - Vaughan, W. P.

AU - Kessinger, A.

AU - Armitage, James Olen

AU - Goldsmith, J. C.

PY - 1990/9/1

Y1 - 1990/9/1

N2 - One hundred sixty‐eight bone marrow transplant recipients and 49 patients who received high‐dose chemotherapy were evaluated for symptomatic thrombosis after Hickman catheter placement. The timing of thrombotic complications was different between these two groups, with the transplant group having a significantly lower thrombus‐free survival by 28 days after catheter placement. By 100 days after placement the thrombus‐free survival rates of the two groups were similar. The platelet count at time of catheter placement was significantly lower in the nontransplant group, and the thrombus‐free survival was longer in patients whose catheter was placed when their platelet count was less than 150,000, suggesting that thrombocytopenia delays thrombotic complications. Placement of two Hickman catheters resulted in a 12.9% thrombosis rate (21 of 162 patients) and was significantly more likely to be associated with thrombosis than placement of one catheter. Long‐term follow‐up evaluation of patients treated without successful fibrinolytic therapy showed no residual symptoms of venous obstruction. In those patients presenting with concomitant catheter obstruction resulting from thrombosis, low‐dose fibrinolytic therapy was successful in restoring catheter function 70% of the time. Placement of two Hickman catheters is associated with an inordinate incidence of thrombosis. Thrombocytopenia at the time of catheter placement may delay this complication. Thrombotic catheter obstruction can be treated successfully with low‐dose fibrinolytic therapy. Even without fibrinolytic therapy, catheter‐induced subclavian vein thrombosis rarely causes long‐term disability.

AB - One hundred sixty‐eight bone marrow transplant recipients and 49 patients who received high‐dose chemotherapy were evaluated for symptomatic thrombosis after Hickman catheter placement. The timing of thrombotic complications was different between these two groups, with the transplant group having a significantly lower thrombus‐free survival by 28 days after catheter placement. By 100 days after placement the thrombus‐free survival rates of the two groups were similar. The platelet count at time of catheter placement was significantly lower in the nontransplant group, and the thrombus‐free survival was longer in patients whose catheter was placed when their platelet count was less than 150,000, suggesting that thrombocytopenia delays thrombotic complications. Placement of two Hickman catheters resulted in a 12.9% thrombosis rate (21 of 162 patients) and was significantly more likely to be associated with thrombosis than placement of one catheter. Long‐term follow‐up evaluation of patients treated without successful fibrinolytic therapy showed no residual symptoms of venous obstruction. In those patients presenting with concomitant catheter obstruction resulting from thrombosis, low‐dose fibrinolytic therapy was successful in restoring catheter function 70% of the time. Placement of two Hickman catheters is associated with an inordinate incidence of thrombosis. Thrombocytopenia at the time of catheter placement may delay this complication. Thrombotic catheter obstruction can be treated successfully with low‐dose fibrinolytic therapy. Even without fibrinolytic therapy, catheter‐induced subclavian vein thrombosis rarely causes long‐term disability.

UR - http://www.scopus.com/inward/record.url?scp=0025145529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025145529&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19900901)66:5<900::AID-CNCR2820660515>3.0.CO;2-A

DO - 10.1002/1097-0142(19900901)66:5<900::AID-CNCR2820660515>3.0.CO;2-A

M3 - Article

C2 - 2386917

AN - SCOPUS:0025145529

VL - 66

SP - 900

EP - 908

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -